• Follow
  • Follow
  • Follow
  • Follow
  • Home
  • About
    • About
    • Education
    • Experience
    • Proficiencies
    • Inventions
    • Book Contributions
    • Research & Publication
    • Honors & Awards
    • Memberships
    • References
  • Media
    • Podcasts
    • Patient Education
    • News
    • Videos
    • Gallery
  • Founder
    • Desert Dream Dentistry & Spa
    • Global Summits Institute
    • Doctors’ World Gala
    • Dental Artificial Intelligence Association (Co-Founder)
    • Universal Fastening System
    • Academy of Oral Surgery
    • Dentistry Fund
    • World’s Top Doctors
    • Hex Commission
    • Dental Hospital Association
    • Doctors’ Dream Team
    • Universal School of Health
  • Contact

RiverGlade Capital sells controlling stake in U.S. Oral Surgery Management

by admin | Nov 22, 2021 | News

The company was formed in 2017 in partnership with Thurston Group as a healthcare management services company to the oral surgery sector.Powered by...

RiverGlade Capital Announces Sale of U.S. Oral Surgery Management

by admin | Nov 19, 2021 | News

RiverGlade Capital (“RiverGlade”), a healthcare-focused private equity firm, is pleased to announce the sale of the firm’s controlling stake …Powered by...

Amarillo Oral & Maxillofacial Surgery announces final winner of ‘Smile Again Program’

by admin | Nov 17, 2021 | News

The Amarillo Oral & Maxillofacial Surgery (AOMS) announced Keri Kirksey as the winner of their fifth annual Smile Again Program. Dr. Paul Wilkinson …Powered by...

Milvexian an effective and safe oral pill for prevention of venous blood clots, says study

by admin | Nov 16, 2021 | News

Researchers compared milvexian with enoxaparin for prevention of blood clots in 1,242 patients from 18 countries undergoing knee replacement surgery who were enrolled between June 2019 and February …Powered by...

Oral Factor XIa Inhibitor Sets the Stage for aSafer Anticoagulant

by admin | Nov 16, 2021 | News

A selective factor XIa inhibitor could make for an effective anticoagulant with a good safety profile, according to a phase II study in elective knee arthroplasty. Larger doses of oral milvexian …Powered by...
« Older Entries
Next Entries »

Recent Posts

  • Robin and Doug Shore Innovation Center April 28, 2026
  • UH demolishes Technology Annex with new Innovation Hub in sight April 28, 2026
  • Alternative lenders gain record share as SBA rules tighten April 28, 2026

Categories

  • News
© Dr. Kianor Shah. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow